Inspite of its shortcomings, The point that the policy is getting rolled out being a trial can be a optimistic factor, reckons Michel Kazatchkine, a member of the worldwide Commission on Drug Policy. The strongest solution to encourage naysayers is through giving cold, tough, irrefutable evidence, he says, and the best way to do that is definitely